#pmmr/mss

1 story

#colorectal cancer #eddingpharm #finance #gb268 #immunotherapy #markets #nmpa #phase 2 trial

Eddingpharm's GB268 Trial Approved in China
China's NMPA clears Eddingpharm's GB268 Phase 2 colorectal cancer trial.
BigGo Finance · 1m